ARCHIVES

FDA Commissioner Mark McClellan tells NCI audience that science is far from eliminating cancer as a threat.

This article is from The Cancer Letter archive.

Vol. 30 No. 06 | February 6, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: ‘WSJ” Articles Call Attention To Problems With Cancer Program Knipmeyer to Leave NCI

May 19, 1989

Vaccine Increases PFS 146%, OS 60% In Phase II Clinical Trial

May 31, 2013

Controversy Continues, Scientists, Advocates, Clinicians Say

January 31, 1997

DCPC Developing Hispanic Cancer Control Intervention Program Concept

August 12, 1988

Afinitor Delayed Progression Compared To Tamoxifen Alone In Randomized Phase II Study

December 31, 2010

Urologists support Approval Of Il-2 for Kidney Cancer

February 1, 1991